Sp1290
EVIDENCE BEYOND CLINICAL TRIALS: STELARA® REAL-WORLD EVIDENCE IN BIO-NAÏVE ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE (CD) OR ULCERATIVE COLITIS (UC)
Date
May 19, 2024
Tracks
Related Products
THE IMPORTANCE OF LONG-TERM CLINICAL OUTCOMES IN BIO-NAIVE PATIENTS
This case based presentation will highlight the importance of long-term clinical outcomes in bio-naive patients across both Crohn's disease and ulcerative colitis. Sponsored by Janssen Biotech, Inc…
RNA SEQUENCING FROM BIOPSIES PERFORMED DURING FOOD ELIMINATION AND REINTRODUCTION IDENTIFIES SIGNATURES INVOLVED IN EARLY RECURRENCE OF EOE
RATIONALE: RNA sequencing studies have previously identified impaired barrier function and the subsequent proinflammatory response as critical to the pathogenies of EoE. However, the investigation into disease initiation is often limited by the inability to capture the disease early…
HYPOALGESIA IN BOTH CROHN'S DISEASE AND ULCERATIVE COLITIS ASSOCIATED WITH HOMOZYGOSITY FOR A NAV1.8 POLYMORPHISM
Background: Postoperative ileus (POI) is a common consequence of abdominal surgery and a neuroinflammation-based disorder of the gastrointestinal tract, which results in motility disturbances compromising patients' recovery…
CB1 RECEPTOR LOCALIZATION WITHIN THE AFFERENT SPLANCHNIC NEURONS AND ITS IMPACT ON FEEDING BEHAVIOR AND ENERGY EXPENDITURE
BACKGROUND: Our previous research has showed that increased sympathetic nervous activity and decreased cannabinoid receptor 1 (CB1) were associated with increased energy expenditure and weight loss following Roux-en-Y gastric bypass (RYGB) in mice…